STAT

Novartis charged much more in the U.S. for some drugs than in other countries

The difference in pricing ranged anywhere from 45 percent to 176 percent, after adjusting for currency fluctuations and packaging.

An axiom in the overheated debate about prescription drug pricing is that Americans are often charged more than what is paid by people in other countries. And internal data from one large drug maker illustrates the point.

In 2014, the most recent year for which data was available, Novartis () headquarters in Switzerland charged its U.S. subsidiary significantly more for four medicines than what its subsidiaries paid in roughly a dozen other countries. These included several well-to-do nations

You're reading a preview, sign up to read more.

More from STAT

STAT3 min readPolitics
Democrats Still Have Questions About Nancy Pelosi’s Drug Pricing Plan
Nancy Pelosi has spent the week pitching her drug pricing plan to Democrats — without actually showing Democrats her drug pricing plan.
STAT4 min read
Purdue Pharma Filed For Bankruptcy. What Does It Mean For Lawsuits Against The Opioid Manufacturer?
Purdue Pharma filed for bankruptcy. What does it mean for lawsuits against the opioid manufacturer?
STAT13 min readPolitics
With Ominous TV Spots And A Senior ‘Strike Force,’ AARP Launches An All-out Attack On Pharma
AARP’s white-haired “strike force,” as the organization calls them, is on the offensive like never before.